HOLX - Hologic, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
43.46
-0.39 (-0.89%)
At close: 4:00PM EST

43.46 0.00 (0.00%)
After hours: 4:38PM EST

Stock chart is not supported by your current browser
Previous Close43.85
Open43.20
Bid35.51 x 100
Ask43.85 x 100
Day's Range42.55 - 43.57
52 Week Range35.76 - 46.80
Volume4,355,482
Avg. Volume2,815,137
Market Cap11.981B
Beta0.61
PE Ratio (TTM)16.46
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga11 hours ago

    Deutsche Bank Downgrades Hologic, Says Core Businesses Face Structural Challenges

    Medical diagnostics products maker Hologic, Inc. (NASDAQ: HOLX ) is likely to be stifled by secular growth challenges on multiple fronts, Deutsche Bank said in a Thursday note. The Analyst Deutsche Bank ...

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markit2 days ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • Moody's3 days ago

    Hologic, Inc. -- Moody's assigns Ba3 rating to Hologic's senior unsecured bonds

    Rating Action: Moody's assigns Ba3 rating to Hologic's senior unsecured bonds. Global Credit Research- 16 Jan 2018. Approximately $1.0 billion of new debt rated.

  • Why Mizuho Securities Upgraded Teva Pharmaceutical to a ‘Buy’
    Market Realist7 days ago

    Why Mizuho Securities Upgraded Teva Pharmaceutical to a ‘Buy’

    Can Teva Pharmaceutical's Restructuring Plan Help It Recuperate?Teva stock upgraded by Mizuho Securities

  • Markit11 days ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • Should You Be Tempted To Buy Hologic Inc (NASDAQ:HOLX) At Its Current PE Ratio?
    Simply Wall St.16 days ago

    Should You Be Tempted To Buy Hologic Inc (NASDAQ:HOLX) At Its Current PE Ratio?

    Hologic Inc (NASDAQ:HOLX) trades with a trailing P/E of 16.1x, which is lower than the industry average of 35.5x. While this makes HOLX appear like a great stock to buy,Read More...

  • Capital Cube21 days ago

    ETFs with exposure to Hologic, Inc. : December 29, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Hologic, Inc. Here are 5 ETFs with the largest exposure to HOLX-US. Comparing the performance and risk of Hologic, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Hologic, Inc. :HOLX-US: Earnings Analysis: Q4, 2017 By the Numbers : December 27, 2017
    Capital Cube24 days ago

    Hologic, Inc. :HOLX-US: Earnings Analysis: Q4, 2017 By the Numbers : December 27, 2017

    Categories: Yahoo FinanceGet free summary analysis Hologic, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Hologic, Inc. – Becton, Dickinson and Company (BDX-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 802.90 million, Net Earnings of USD 82.70 million. ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to Hologic, Inc. : December 18, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Hologic, Inc. Here are 5 ETFs with the largest exposure to HOLX-US. Comparing the performance and risk of Hologic, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Benzingalast month

    Cowen: Hologic Is A Relatively Cheap Stock Overdue For Upside

    Valuation of Hologic, Inc. (NASDAQ: HOLX ) — which manufactures diagnostic products, medical imaging systems and surgical products — is attractive, according to a Cowen analyst.  The Analyst Cowen analyst ...

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markitlast month

    See what the IHS Markit Score report has to say about Hologic Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding HOLX is favorable, with net inflows of $16.58 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing.

  • Hologic (HOLX) Up 8% Since Earnings Report: Can It Continue?
    Zackslast month

    Hologic (HOLX) Up 8% Since Earnings Report: Can It Continue?

    Hologic (HOLX) reported earnings more than 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • TheStreet.comlast month

    Six Off the Beaten Path Healthcare Stock Gems

    These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.

  • Capital Cubelast month

    ETFs with exposure to Hologic, Inc. : December 8, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Hologic, Inc. Here are 5 ETFs with the largest exposure to HOLX-US. Comparing the performance and risk of Hologic, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Benzingalast month

    Hologic: Meet Goldman Sach's New 'Conviction Buy'

    Hologic, Inc. (NASDAQ: HOLX ) — the manufacturer of diagnostic products, medical imaging systems and surgical products — is being added to Goldman Sachs' conviction list . The list is made up of Goldman's ...

  • Hologic's Panther Fusion Flu AdV/hMPV/RV Assay Wins FDA Nod
    Zackslast month

    Hologic's Panther Fusion Flu AdV/hMPV/RV Assay Wins FDA Nod

    Hologic's (HOLX) recent spree of regulatory approvals for its array of products is encouraging.

  • Hologic Banks on Molecular Diagnostics, Competition Rife
    Zackslast month

    Hologic Banks on Molecular Diagnostics, Competition Rife

    Hologic (HOLX) gains on increasing market share and utilization of fully-automated Panther system.

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markitlast month

    See what the IHS Markit Score report has to say about Hologic Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • Reuters2 months ago

    FDA panel recommends Zika testing of donated blood be relaxed

    Advisers to the U.S. Food and Drug Administration on Friday recommended that the requirements for screening blood donations for the Zika virus be relaxed due to diminished risk of transfusion-transmitted infection. The advisory panel voted that instead of requiring Zika virus testing on each individual blood donation, tests could be conducted on "mini-pools" in which blood samples are pooled before testing. In 2016 the FDA advised U.S. blood centers to screen all blood donations for Zika.

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • Capital Cube2 months ago

    ETFs with exposure to Hologic, Inc. : November 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Hologic, Inc. Here are 5 ETFs with the largest exposure to HOLX-US. Comparing the performance and risk of Hologic, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Hologic (HOLX) Focuses on Breast Health, Ties Up with Clarius
    Zacks2 months ago

    Hologic (HOLX) Focuses on Breast Health, Ties Up with Clarius

    Hologic (HOLX) forges ahead with its efforts to strengthen hold in the high potential breast cancer screening market.

  • Hologic's FDA Nod for Quantra Software Boosts Breast Health
    Zacks2 months ago

    Hologic's FDA Nod for Quantra Software Boosts Breast Health

    Hologic (HOLX) is consistently trying to boost its Breast Health segment.

  • Hologic, Inc. :HOLX-US: Earnings Analysis: 2017 By the Numbers : November 27, 2017
    Capital Cube2 months ago

    Hologic, Inc. :HOLX-US: Earnings Analysis: 2017 By the Numbers : November 27, 2017

    Categories: Yahoo FinanceGet free summary analysis Hologic, Inc. reports financial results for the year ended September 30, 2017. We analyze the earnings along side the following peers of Hologic, Inc. – Thermo Fisher Scientific Inc., Becton, Dickinson and Company, C. R. Bard, Inc., Boston Scientific Corporation, Abbott Laboratories, Johnson & Johnson, Quest Diagnostics Incorporated, General Electric Company ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Hologic Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Hologic Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.